Clinical Trial

¹⁹F (Perfluoropropane) MRI

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Healthy volunteers aged 18 to 85 will undergo ¹⁹F (perfluoropropane) MRI to support the development of imaging sequences, reconstruction algorithms, and hardware necessary for acquiring high-spatial resolution lung images. The study will also evaluate signal-to-noise ratio, contrast-to-noise ratio, spatial resolution, scan duration, and pulmonary gas exchange measurements derived from ¹⁹F (perfluoropropane) MRI.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-04-23
notable Primary completion pushed: 2030-06-30 -> 2030-08-30 2026-04-23
Trial Details
NCT Number NCT07305532
Lead Sponsor Alexei Ouriadov
Collaborators: St. Joseph's Health Care London
Conditions Healthy Volunteers - Male and Female
Enrollment 200 participants
Start Date 2026-05-20
Primary Completion 2030-08-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-22